| First Author | Antila S | Year | 2024 |
| Journal | Nat Cardiovasc Res | Volume | 3 |
| Pages | 474-491 | PubMed ID | 39087029 |
| Mgi Jnum | J:358640 | Mgi Id | MGI:7782716 |
| Doi | 10.1038/s44161-024-00445-9 | Citation | Antila S, et al. (2024) Sustained meningeal lymphatic vessel atrophy or expansion does not alter Alzheimer's disease-related amyloid pathology. Nat Cardiovasc Res 3:474-491 |
| abstractText | Discovery of meningeal lymphatic vessels (LVs) in the dura mater, also known as dural LVs (dLVs) that depend on vascular endothelial growth factor C expression, has raised interest in their possible involvement in Alzheimer's disease (AD). Here we find that in the APdE9 and 5xFAD mouse models of AD, dural amyloid-beta (Abeta) is confined to blood vessels and dLV morphology or function is not altered. The induction of sustained dLV atrophy or hyperplasia in the AD mice by blocking or overexpressing vascular endothelial growth factor C, impaired or improved, respectively, macromolecular cerebrospinal fluid (CSF) drainage to cervical lymph nodes. Yet, sustained manipulation of dLVs did not significantly alter the overall brain Abeta plaque load. Moreover, dLV atrophy did not alter the behavioral phenotypes of the AD mice, but it improved CSF-to-blood drainage. Our results indicate that sustained dLV manipulation does not affect Abeta deposition in the brain and that compensatory mechanisms promote CSF clearance. |
